Background: Elevated D-dimer levels have been observed in COVID-19 and are of prognostic value, but have not been compared to an appropriate control group.

Methods: Observational cohort study including emergency patients with suspected or confirmed COVID-19. Logistic regression defined the association of D-dimer levels, COVID-19 positivity, age, and gender with 30-day-mortality.

Results: 953 consecutive patients (median age 58, 43% women) presented with suspected COVID-19: 12 (7.4%) patients with confirmed SARS-CoV-2-infection died, compared with 28 (3.5%) patients without SARS-CoV-2-infection. Overall, most (56%) patients had elevated D-dimer levels (≥0.5mg/l). Age (OR 1.07, CI 1.05-1.10), D-dimer levels ≥0.5mg/l (OR 2.44, CI 0.98-7.39), and COVID-19 (OR 2.79, CI 1.28-5.80) were associated with 30-day-mortality.

Conclusion: D-dimer levels are effective prognosticators in both patient groups.

References

1. Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Internal Medicine. 2020.
2. Covino M, De Matteis G, Burzo ML, et al. Predicting In Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores. Journal of the American Geriatrics Society.2020.
3. Grossmann FF, Nickel CH, Christ M, et al. Transporting clinical tools to new settings: cultural adaptation and validation of the Emergency Severity Index in German. Annals of emergency medicine. 2011;57(3):257-264.
4. Arachchillage DR, Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 2020;18(5):1233-1234.
5. Miesbach W, Makris M. COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clinical and Applied Thrombosis/Hemostasis. 2020;26:1076029620938149.
6. Lyngholm LE, Nickel CH, Kellett J, et al. A negative D-dimer identifies patients at low risk of death within 30 days: a prospective observational emergency department cohort study. QJM: An International Journal of Medicine. 2019;112(9):675-680.
7. Rodelo JR, De la Rosa G, Valencia ML, et al. D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. The American journal of emergency medicine. 2012;30(9):1991-1999.
8. Di Castelnuovo A, De Curtis A, Costanzo S, et al. Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study. Haematologica.2013;98(9):1476-1480.
9. Yang XY, Gao S, Ding J, et al. Plasma d-dimer predicts shortterm poor outcome after acute ischemic stroke. PloS one.2014;9(2):e89756.
10. Szymanski FM, Karpinski G, Filipiak KJ, et al. Usefulness of the D-dimer concentration as a predictor of mortality in patients without-of-hospital cardiac arrest. The American journal of cardiology.2013;112(4):467-471.
11. Brüggemann RA, Spaetgens B, Gietema HA, et al. The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison. Thrombosis Research. 2020;196:486-490.
12. Mouhat B, Besutti M, Bouiller K, et al. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.
    European Respiratory Journal. 2020;56(4).
13. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA : the journal of the American Medical Association. 2020;323(11):1061-1069.
14. Nickel CH, Kellett J, Cooksley T, et al. The diagnoses and outcomes of emergency patients with an elevated D-dimer over the next 90 days. The American Journal of Medicine. 2020.
15. Physicians RCo. National Early Warning Score (NEWS) 2.
16. Smith GB, Prytherch DR, Meredith P, et al. The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation. 2013;84(4):465-470.
17. Nickel CH, Kellett J, Cooksley T, et al. Combined use of the National Early Warning Score and D-dimer levels to predict 30- day and 365-day mortality in medical patients. Resuscitation.2016;106:49-52.
18. Lyngholm L, Nickel C, Kellett J, et al. Normal gait, albumin and d-dimer levels identify low risk emergency department patients: a prospective observational cohort study with 365-day 100% followup. QJM: An International Journal of Medicine. 2020;113(2):86-92.
19. Nickel C, Kuster T, Keil C, et al. Risk stratification using D-dimers in patients presenting to the emergency department with nonspecific complaints. European journal of internal medicine. 2016;31:20-24.
20. Li C, Hu B, Zhang Z, et al. D-dimer triage for COVID-19. Academic Emergency Medicine. 2020.
21. Li Y, Zhao K, Wei H, et al. Dynamic relationship between D-dimer and COVID-19 severity. British Journal of Haematology. 2020.
22. Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in hospital mortality in patients with Covid-19. Journal of Thrombosis and Haemostasis. 2020;18(6):1324-1329.
23. Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thrombosis and haemostasis. 2020;120(5):876.
24. Mansella G, Rueegg M, Widmer AF, et al. COVID-19 Triage and Test Center: Safety, Feasibility, and Outcomes of Low-Threshold Testing. Journal of clinical medicine. 2020;9(10):3217.
25. Bingisser R, Baerlocher SM, Kuster T, et al. Physicians’ Disease Severity Ratings are Non-Inferior to the Emergency Severity Index. Journal of Clinical Medicine. 2020;9(3):762.
26. Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Annals of internal medicine. 2007;147(8):573-577.
27. Gelman A, Jakulin A, Pittau MG, et al. A weakly informative default prior distribution for logistic and other regression models. Annals of applied Statistics. 2008;2(4):1360-1383.
28. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA : the journal of the American Medical Association. 2020;323(13):1239-1242.
29. Haimovich AD, Ravindra NG, Stoytchev S, et al. Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation. Annals of emergency medicine. 2020;76(4):442-453.
30. Ji D, Zhang D, Xu J, et al. Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score. Clinical Infectious Diseases. 2020;71(6):1393-1399.
31. Shi Y, Yu X, Zhao H, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Critical care. 2020;24(1):1-4.
32. Altschul DJ, Unda SR, Benton J, et al. A novel severity score to predict inpatient mortality in COVID-19 patients. Scientific reports. 2020;10(1):1-8.
33. Brabrand M, Bogh SB, Fløjstrup M, et al. Routine measurement of d-dimers on suspected SARS-CoV2-infected patients does not lead to significant increase in radiological investigations. Intern Emerg Med. 2021:1-2.
34. Lippi G, Bonfanti L, Saccenti C, et al. Causes of elevated D-dimer in patients admitted to a large urban emergency department. European journal of internal medicine. 2014;25(1):45-48.
35. Shorr A, Trotta R, Alkins S, et al. D-dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease. Intensive care medicine. 1999;25(2):207-210.
36. Haase C, Joergensen M, Ellervik C, et al. Age-and sex-dependent reference intervals for D-dimer: evidence for a marked increase by age. Thrombosis research. 2013;132(6):676-680.
37. Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA : the journal of the American Medical Association. 2014;311(11):1117-1124.
38. Dalager-Pedersen M, Lund LC, Mariager T, et al. Venous thromboembolism and major bleeding in patients with COVID-19: A nationwide population-based cohort study. Clinical Infectious Diseases. 2021.
39. Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421-1424.
40. Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147.
41. Couturaud F, Bertoletti L, Pastre J, et al. Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms. JAMA : the journal of the American Medical Association. 2021;325(1):59-68.
42. Aleva FE, Voets L, Simons SO, et al. Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis. Chest. 2017;151(3):544-554.
43. Pimentel MA, Redfern OC, Hatch R, et al. Trajectories of vital signs in patients with COVID-19. Resuscitation. 2020;156:99-106.
44. Kostakis I, Smith GB, Prytherch D, et al. The performance of the National Early Warning Score and National Early Warning Score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Resuscitation. 2020.
45. Peng X, Subbe CP, Zhang L, et al. NEWS can predict deterioration of patients with COVID-19. Resuscitation. 2020;152:26-27.
46. Ortega RN, Rosin C, Bingisser R, et al. Clinical scores and formal triage for screening of sepsis and adverse outcomes on arrival in an emergency department all-comer cohort. The Journal of emergency medicine. 2019;57(4):453-460. e452.